STAT3 and breast carcinoma: Hedgehog pathway inhibitors (e.g., Vismodegib in basal cell carcinoma)STAT3 inhibitors (e.g., Napabucasin in pancreatic cancer). Notch signalling pathway inhibitors in breast cancer.Hedgehog pathway inhibitors in medulloblastoma (207, 212–214).